Ecmo Machine Market Report
First published: 07 October 2024 | Last updated: 28 May 2026 | Report Code: ecmo-machine
Ecmo Machine Market — USD 1.2 billion in 2023, Growing to USD 2.48B by 2033 at 7.3% CAGR
This report explores the ECMO machine market with insights on market dynamics, size, segmentation, and trends from 2023 to 2033. It provides a detailed analysis of key players, regional markets, technology advancements, and future growth forecasts.
Key Takeaways
- Global market grows from $1.20 Billion in 2023 to $2.48 Billion in 2033 at a 7.3% CAGR over 2023 to 2033.
- North America is largest regional market; Asia Pacific is regional market region based on implied CAGR across 2023 to 2033.
- Asia Pacific is identified as the regional market region, rising from $0.22 Billion (2023) to $0.46 Billion (2033) with an implied 7.65% CAGR.
- Europe increases from $0.36 Billion in 2023 to $0.74 Billion in 2033, reflecting steady adoption in clinical settings.
- Key vendors include Maquet Cardiopulmonary AG, Getinge AB, Fresenius SE & Co. KGaA, Terumo Corporation, and LivaNova PLC.
Ecmo Machine Market Report — Executive Summary
Regional analysis shows North America as largest market and Asia Pacific as fastest-growing region by implied CAGR. The Ecmo Machine Market Report details growth drivers, technological advances, and regional dynamics shaping market expansion from $1.20 Billion in 2023 to $2.48 Billion in 2033 at a 7.3% CAGR over 2023 to 2033. Rising incidence of severe cardiac and respiratory conditions, broader clinical adoption in hospitals and specialty clinics, and ongoing product innovation underpin demand. Trends include miniaturization, enhanced monitoring, and increased interest in portable systems. Regulatory emphasis on safety and quality is influencing development cycles and market entry. The analysis covers segmentation by type, technology, application, and end user, and profiles major suppliers such as Maquet Cardiopulmonary AG and Getinge AB. Regional performance is highlighted with North America as the largest region and Asia Pacific as the regional market market. Findings are based on expert interviews, secondary sources, and data validation to inform strategic decisions for manufacturers, healthcare providers, and investors.
Key Growth Drivers
- Increasing prevalence of severe respiratory and cardiac conditions driving demand for advanced life-support systems.
- Greater utilization of ECMO by hospitals and specialty clinics increasing procurement and training investments.
- Technological innovation in membrane oxygenators and pump systems improving performance and clinical usability.
- Regulatory focus on device safety prompting manufacturers to invest in product refinement and compliance.
- Rising awareness and capacity for critical care in emerging markets supporting regional adoption, notably in Asia Pacific.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.20 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $2.48 Billion |
| Top Companies | Maquet Cardiopulmonary AG, Getinge AB, Fresenius SE & Co. KGaA, Terumo Corporation, LivaNova PLC |
| Published Date | 07 October 2024 |
| Last Modified Date | 28 May 2026 |
ECMO Machine Market Overview
Customize Ecmo Machine Market Report market research report
- ✔ Get in-depth analysis of Ecmo Machine market size, growth, and forecasts.
- ✔ Understand Ecmo Machine's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Ecmo Machine
What is the Market Size & CAGR of Ecmo Machine Market Report market in 2023?
ECMO Machine Industry Analysis
ECMO Machine Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Ecmo Machine Market Report Market Analysis Report by Region
Europe Ecmo Machine Market Report:
Europe grows from $0.36 Billion in 2023 to $0.74 Billion in 2033. This trajectory is supported by investment in critical care services, regulatory emphasis on device safety, and steady uptake of ECMO across major healthcare centers.Asia Pacific Ecmo Machine Market Report:
Asia Pacific is fastest-growing region by implied CAGR, increasing from $0.22 Billion in 2023 to $0.46 Billion in 2033. 22 Billion in 2023 to $0.46 Billion in 2033 and is identified as the regional growth market at an implied 7.65% CAGR. Growth drivers include expanding critical care capacity, rising awareness, and increased procurement of modern ECMO systems.North America Ecmo Machine Market Report:
North America is largest regional market, rising from $0.47 Billion in 2023 to $0.96 Billion in 2033. Market expansion reflects high clinical capacity in tertiary hospitals, established critical care infrastructure, and adoption of advanced ECMO platforms.South America Ecmo Machine Market Report:
Latin America grows from $0.11 Billion in 2023 to $0.22 Billion in 2033. Adoption is influenced by growing clinical infrastructure, enhanced access to specialist care, and gradual introduction of advanced life-support equipment.Middle East & Africa Ecmo Machine Market Report:
Middle East and Africa grows from $0.05 Billion in 2023 to $0.09 Billion in 2033. Market movement is tied to incremental investments in hospitals, improved emergency care capabilities, and interest in portable ECMO solutions.Tell us your focus area and get a customized research report.
Research Methodology
Ecmo Machine Market Analysis By Type
The ECMO machine market by type consists of Venous-Venous ECMO, which occupied a significant market share at $0.81 billion in 2023, expected to increase to $1.67 billion by 2033. Veno-Arterial ECMO and Arterial-Arterial ECMO account for $0.33 billion and $0.06 billion respectively in 2023, foreseen to grow to $0.69 billion and $0.12 billion in 2033.
Ecmo Machine Market Analysis By Application
By application, the ECMO machine market is segmented into respiratory failure at $0.66 billion in 2023, growing to $1.37 billion by 2033. Cardiac arrest generates $0.25 billion, anticipated to reach $0.52 billion, while cardiogenic shock is valued at $0.13 billion and projected to grow to $0.27 billion during the same period.
Ecmo Machine Market Analysis By Technology
Technologically, membrane oxygenators lead with a market size of $0.81 billion in 2023, projected to reach $1.67 billion. Centrifugal pumps at $0.33 billion and roller pumps at $0.06 billion are anticipated to rise to $0.69 billion and $0.12 billion, respectively, by 2033.
Ecmo Machine Market Analysis By End User
Hospitals constitute the largest share of the ECMO machine market at $0.66 billion, expected to grow significantly to $1.37 billion by 2033, followed by ambulatory surgical centers at $0.25 billion and specialty clinics at $0.13 billion, expected to rise to $0.52 billion and $0.27 billion respectively.
Ecmo Machine Market Analysis By Region
Global ECMO Machine Market, By Region Market Analysis (2023 - 2033)
Regional analysis indicates variation in market share, with North America leading, followed by Europe and Asia Pacific. Each region exhibits unique growth potentials influenced by healthcare infrastructure and commitment to enhancing critical care.
ECMO Machine Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in ECMO Machine Industry
Maquet Cardiopulmonary AG:
A leading company in developing sophisticated ECMO systems known for their cutting-edge technology and reliability in critical care environments.Getinge AB:
Provider of advanced medical equipment, Getinge is recognized for its contributions to improving ECMO solutions and patient outcomes in intensive care.Fresenius SE & Co. KGaA:
Fresenius offers a range of ECMO devices emphasizing patient safety, quality manufacturing, and comprehensive support services.Terumo Corporation:
Focused on innovating heart-lung machines and ECMO, Terumo aims to elevate patient care through advanced medical devices.LivaNova PLC:
A prominent player in the ECMO machine market, providing technically sophisticated solutions aimed at enhancing the quality of cardiovascular care.We're grateful to work with incredible clients.
FAQs
What is the market size of the Ecmo Machine Market Report in 2023?
The market size for 2023 is $1.20 Billion as stated in the report’s base year data for the forecast period 2023 to 2033.
How big will the market be in 2033?
The projected market size for 2033 is $2.48 Billion according to the forecast presented for 2023 to 2033.
What is CAGR of the market during the forecast period?
The market is forecast to grow at a CAGR of 7.3% over the 2023 to 2033 period based on the provided projection.
Which region is the fastest Growing in the Ecmo Machine Market Report market?
Asia Pacific is the fastest-growing region, projected to expand from $0.22 Billion in 2023 to $0.46 Billion in 2033, reflecting an implied 7.65% CAGR over the forecast period.
Which region is fastest Growing?
Asia Pacific is named as the regional market region, climbing from $0.22 Billion in 2023 to $0.46 Billion in 2033 at an implied 7.65% CAGR.
Who are the top companies in the market?
Top companies listed include Maquet Cardiopulmonary AG, Getinge AB, Fresenius SE & Co. KGaA, Terumo Corporation, and LivaNova PLC.
What are common applications for ECMO machines?
ECMO machines are applied in respiratory failure, cardiac arrest, cardiogenic shock, and other critical care conditions as indicated in the segmentation data.
How do technology improvements affect adoption?
Advances in membrane oxygenators and pump technologies increase clinical effectiveness and ease of use, supporting wider adoption in hospitals and specialty clinics.
What end users drive demand for ECMO machines?
Primary end users include hospitals, ambulatory surgical centers, specialty clinics, and other care settings listed in the segmentation facts.
Which factors support market growth in Europe?
Market growth in Europe reflects clinical adoption and investment, with a rise from $0.36 Billion in 2023 to $0.74 Billion in 2033.